Published in Proc Soc Exp Biol Med on January 01, 1960
Specific serum agglutination of erythrocytes sensitized with extracts of tubercle bacilli. J Exp Med (1948) 11.08
Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis (1963) 9.11
Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health (1958) 3.71
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report. Am Rev Tuberc (1954) 3.36
An apparatus for airborne infection of mice. Proc Soc Exp Biol Med (1952) 3.07
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc (1954) 2.98
Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc (1954) 2.62
The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol (1955) 2.60
A hemolytic modification of the hemagglutination test for antibodies against tubercle bacillus antigens. J Clin Invest (1950) 2.46
Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science (1953) 2.29
Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest (1959) 2.20
Cytochemical reaction of virulent tubercle bacilli. Am Rev Tuberc (1948) 2.14
Antigens of tubercle bacillus involved in hemagglutination and hemolysis reactions. Bull N Y Acad Med (1952) 1.98
Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc (1952) 1.93
The effect of wetting agents on the growth of tubercle bacilli. J Exp Med (1948) 1.90
Interface enrichment of methylene blue by fatty acids with microanalytic applications. Science (1957) 1.84
Immunological aspects of airborne infection: reactions to inhaled antigens. Bacteriol Rev (1961) 1.72
Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro. Am Rev Tuberc (1954) 1.63
INFECTIVITY, PATHOGENICITY AND SULPHOLIPID FRACTION OF SOME INDIAN AND BRITISH STRAINS OF TUBERCLE BACILLI. Tubercle (1963) 1.43
The experimental analysis of virulence of tubercle bacilli. Bull N Y Acad Med (1950) 1.36
The hemagglutination test in tuberculosis. Am Rev Tuberc (1950) 1.35
The effects of some sulfhydryl compounds on growth of catalase-positive and catalase-negative tubercle bacilli. Am Rev Tuberc (1956) 1.35
Peripheral neuritis in tuberculous patients treated with isoniazid. Am Rev Tuberc (1954) 1.29
Studies on the gaseous content of tuberculous cavities. Am Rev Respir Dis (1959) 1.29
[A case of human infection by Mycobacterium ulcerans in the western hemisphere; preliminary note]. Int J Lepr (1954) 1.24
Chemotherapy of tuberculosis. Adv Intern Med (1956) 1.21
Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci (1957) 1.16
Effect of para-aminosalicylic acid on serum isoniazid levels in man. Proc Soc Exp Biol Med (1956) 1.16
Changing concepts in the treatment of pulmonary tuberculosis. Ann Intern Med (1957) 1.16
Airborne immunization against tuberculosis. Science (1958) 1.13
Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis. Am Rev Tuberc (1955) 1.13
Techniques of drug-resistance tests. Am Rev Tuberc (1954) 1.12
Infectivity and pathogenicity of Indian and British strains of tubercle bacilli studied by aerogenic infection of guinea pigs. Am Rev Respir Dis (1963) 1.10
Observations on the pathogenicity of isoniazid-resistant mutants of tubercle bacilli for tuberculous patients. Am Rev Tuberc (1955) 1.06
Clinical evaluation of isoniazid. Am Rev Tuberc (1954) 1.02
Dosages of isoniazid and streptomycin for routine chemotherapy of tuberculosis. Tubercle (1960) 0.99
Tuberculin hypersensitivity in tuberculous infants treated with isoniazid. N Engl J Med (1955) 0.98
Comparative study of the vaccinating properties of BCG and its isoniazid-resistant mutant in guinea pigs. Am Rev Tuberc (1957) 0.97
Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med (1956) 0.95
Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients. J Clin Invest (1959) 0.93
Carbon dioxide-impermeable plastic bags for artificial cultivation of tubercle bacilli. Am Rev Respir Dis (1963) 0.90
Combined drug treatment of tuberculosis. III. Clinical application of the principles of appropriate and adequate chemotherapy to the treatment of pulmonary tuberculosis. J Clin Invest (1959) 0.90
Media for tubercle bacilli. Am Rev Tuberc (1947) 0.87
The handling of the poor risk patient with pulmonary tuberculosis: antimicrobial therapy, cardio-pulmonary function and surgery. Dis Chest (1956) 0.82
Quantitative inhalation challenge in allergic asthma. J Allergy (1963) 0.81
DYNAMIC ASPECTS OF THE STERILIZING ACTION OF ISONIAZID ON MYCOBACTERIUM TUBERCULOSIS. Am Rev Respir Dis (1963) 0.81
Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest (1959) 0.79
Ambulation of patients with pulmonary tuberculosis under protection of chemotherapy; a preliminary report. Am Rev Tuberc (1954) 0.79
Fatal tuberculous meningitis developing during isoniazid-streptomycin therapy. Am Rev Tuberc (1955) 0.79
Chemoprophylaxis with isoniazid against aerogenic tuberculous infection in the guinea pig. Am Rev Respir Dis (1962) 0.77
Laboratory aids to diagnosis and therapy. Annu Rev Med (1954) 0.76
[Various new data on the biology of Koch's bacillus (referring to a recent report)]. Medicina (B Aires) (1954) 0.75
BACTERICIDAL EFFECT OF ISONIAZID AS A FUNCTION OF TIME. Am Rev Respir Dis (1965) 0.75
THE EFFECT OF NEAR-ULTRAVIOLET LIGHT ON CULTURE MEDIA. Am Rev Respir Dis (1965) 0.75
Tuberculosis in childhood: some aspects of prevention, diagnosis and treatment. J Ky State Med Assoc (1958) 0.75
Differential characteristics of virulent and avirulent variants of mammalian tubercle bacilli. J Bacteriol (1947) 0.75
Studies on the effect of various derivatives of para-aminosalicylic acid on serum levels of antimicrobially active isoniazid. Acta Tuberc Scand (1960) 0.75
Effect of increasing dosage of streptomycin sulfate on serum levels of antimicrobially active drug. Dis Chest (1961) 0.75
THE EFFECT OF NEAR-ULTRAVIOLET LIGHT ON STAPHYLOCOCCI AND MYCOBACTERIA IN DROPLET NUCLEI. Am Rev Respir Dis (1965) 0.75
Developments in the laboratory: the growth requirements and pathogenic properties of isoniazid-resistant tubercle bacilli. Trans Annu Meet Natl Tuberc Assoc (1954) 0.75
Attenuation of isoniazid-resistant mutants of tubercle bacilli and host hypersensitivity to tuberculin. Proc Soc Exp Biol Med (1955) 0.75
The open-negative problem. Am Rev Respir Dis (1959) 0.75
[A plan for the treatment of pulmonary tuberculosis. II. Experiences in 173 patients with streptomycin and isoniazid-senstive tubercle bacilli]. Med Nov (1959) 0.75
The residual lesion in pulmonary tuberculosis requiring surgery. A review of 100 sputum-negative patients consecutively operated on. N Engl J Med (1960) 0.75
Some thoughts on results following intermittent streptomycin in pulmonary tuberculosis. Dis Chest (1959) 0.75
THE INFECTIVITY AND PATHOGENICITY OF INDIAN TUBERCLE BACILLI. Am Rev Respir Dis (1963) 0.75
Pathogenesis of atherosclerosis. Rocky Mt Med J (1955) 0.75
Medical treatment of tuberculosis: preliminary report on early ambulation of tuberculous patients under the cover of chemotherapy. Trans Annu Meet Natl Tuberc Assoc (1954) 0.75
Certain effects of streptomycin on mycobacteria in vitro. Am Rev Tuberc (1946) 0.75
Comparative susceptibilities of different strains of mice to experimental infection with mammalian tubercle bacilli. J Bacteriol (1947) 0.75
Healing of the open cavity in pulmonary tuberculosis under chemotherapy. Am Rev Tuberc (1956) 0.75
Effect of pyrazinamide on antimicrobially active serum isoniazid. Dis Chest (1960) 0.75
Tuberculin testing, chemoprophylaxis, and BCG vaccination. Isr Med J (1959) 0.75
Isoniazid resistance. Lancet (1955) 0.75
Infection of mice with tubercle bacilli grown in tween-albumin liquid medium. Proc Soc Exp Biol Med (1947) 0.75
Biologic changes in sulfonamide-resistant Mycobacterium ranae. J Bacteriol (1946) 0.75
Chemotherapy of childhood tuberculosis. Am J Dis Child (1961) 0.75
The treatment of primary tuberculosis in infancy. J Pediatr (1955) 0.75
[A plan for the treatment of pulmonary tuberculosis. I. Experiences in 173 patients with streptomycin- and isoniazid-sensitive tubercle bacilli]. Med Nov (1959) 0.75
Effect of pyridoxine on concentrations of active isoniazid in serum. Am Rev Respir Dis (1960) 0.75
Serologic reaction in tuberculosis. Am Rev Tuberc (1948) 0.75
The binding of various long-chain fatty acids by serum albumin. Clin Chim Acta (1957) 0.75
The effect of tubercle bacilli on the antigenicity of a synthetic ester of oleic acid. J Immunol (1947) 0.75